BCL2 and neoplasm: Due to the important roles of antiapoptotic Bcl-2 proteins for tumor cell survival, combinations of inhibitors for antiapoptotic Bcl-2 proteins (BH3 mimetics) with MAPK inhibitors appear to be promising strategies.